Arjo AB (publ) (STO:ARJO.B)
Sweden · Delayed Price · Currency is SEK 29.10
-0.26 (-0.89%)
Sep 2, 2026, 5:29 PM CET
Arjo AB Market Cap
Arjo AB has a market cap or net worth of 8 billion as of September 2, 2026. Its market cap has decreased by -14.00% in one year.
Market Cap
8.00B
Enterprise Value
12.79B
Revenue
10.92B
Ranking
n/a
PE Ratio
20.82
Stock Price
29.10
ChartMarket Cap Chart
Since December 12, 2017, Arjo AB's market cap has increased from 6.71B to 8.00B, an increase of 19.20%. That is a compound annual growth rate of 2.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 8.00B | -8.31% |
| Dec 30, 2025 | 8.72B | -11.69% |
| Dec 30, 2024 | 9.88B | -7.97% |
| Dec 29, 2023 | 10.73B | 1.18% |
| Dec 30, 2022 | 10.61B | -64.86% |
| Dec 30, 2021 | 30.18B | 76.29% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 156.21B |
| Getinge AB | 66.43B |
| Sectra AB | 56.88B |
| Medicover AB | 36.85B |
| BioGaia AB | 11.60B |
| MedCap AB | 8.39B |
| Synsam AB | 8.33B |
| Xvivo Perfusion AB | 8.31B |